安琪酵母(600298.SH):與森瑞斯成立合資公司 推進以合成生物技術為基礎開發工業大麻和新材料橡膠的生產中試及其產業化項目
格隆匯5月21日丨安琪酵母(600298.SH)公佈,公司與森瑞斯生物科技(深圳)有限公司(以下簡稱森瑞斯)成立合資公司,共同推進以合成生物技術為基礎開發工業大麻和新材料橡膠的生產中試及其產業化項目。首期註冊資本1000萬元人民幣,其中安琪出資400萬元人民幣。
森瑞斯以部分現金加CBD、CBG以及新材料橡膠三個項目的知識產權評估價值的方式出資入股,最終持股比例60%;安琪以現金方式出資入股,最終持股比例40%。
森瑞斯是在合成生物學領域從事相關新技術與新產品開發的高科技公司,成立於2019年5月,當前已經完成了通過生物途徑在釀酒酵母細胞中成功合成大麻二酚與大麻萜酚(英文簡稱分別是CBD、CBG),以及液體新材料橡膠的實驗室中試,並已經申請擁有了這三個產品相關技術的自主知識產權。森瑞斯與安琪之間不存在產權、業務、資產、債權債務、人員等方面的關聯關係。
森瑞斯當前仍然處於初創階段,截至2020年12月31日,森瑞斯資產總額1452.20萬元,負債總額91.10萬元,淨資產1361.10萬元,2020年尚未實現營業收入,淨利潤-568.29萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.